Activity of mecillinam against USA urinary tract clinical isolates from 2017 to 2020 including isolates resistant to comparator antibiotics
The data further support the clinical development and clinical utility of mecillinam. © 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
Authors
- Federica Monti (ORCID: https://orcid.org/0009-0008-7932-0096)
- Nimmi Kothari
- Stephen Hawser (ORCID: https://orcid.org/0000-0001-7607-0767)
- Anne Santerre Henriksen (ORCID: https://orcid.org/0000-0002-7294-6386)
- Ian Morrissey (ORCID: https://orcid.org/0000-0001-8254-9651)
Institutions
- British Society for Antimicrobial Chemotherapy (GB)
- Sarmap (Switzerland) (CH)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1016/j.jgar.2024.08.013
- Citations
- 5
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 1.93